✦ LIBER ✦

A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumors

✍ Scribed by A. Felici; W. J. Loos; J. Verweij; I. Cirillo; P. de Bruijn; K. Nooter; R. H. J. Mathijssen; M. J. A. de Jonge

Publisher: Springer
Year: 2006
Tongue: English
Weight: 283 KB
Volume: 58
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-006-0221-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of sequential cisplatin p

Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma

✍ Fotios Loupakis; Gianluca Masi; Lorenzo Fornaro; Enrico Vasile; Giacomo Allegrin 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 233 KB

Phase II trial of irinotecan plus cispla

Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck

✍ Jill Gilbert; Anthony Cmelak; Yu Shyr; James Netterville; Brian B. Burkey; Rober 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

A phase II study of 5-fluorouracil, leuc

A phase II study of 5-fluorouracil, leucovorin, and interferon-α in the treatment of patients with metastatic or recurrent gastric carcinoma : An Eastern Cooperative Oncology Group study (E5292)

✍ Gary R. Hudes; Stuart Lipsitz; Jean Grem; Mary Morrisey; Louis Weiner; John W. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Chemotherapy has a limited impact on adenocarcinoma of the stomach. Although biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (LV) and interferon-␣ (IFN-␣) has improved the outcomes of patients with metastatic colorectal carcinoma compared with 5-FU alone, this approach has not been ext

All-trans retinoic acid and interferon-α

All-trans retinoic acid and interferon-α-2a in patients with metastatic or recurrent carcinoma of the uterine cervix : Clinical and pharmacokinetic studies

✍ Scott Wadler; Edward L. Schwartz; Hilda Haynes; Ronalde Rameau; Astrid Quish; Jo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## Background: Recent clinical trials with a combination of interferon (ifn alpha) and 13 cis-retinoic acid resulted in high response rates among women with locally advanced and metastatic carcinoma of the uterine cervix. the authors sought to amplify these observations by employing the isomer of 1

Hyperthermia for the treatment of patien

Hyperthermia for the treatment of patients with malignant germ cell tumors : A Phase I/II study in ten children and adolescents with recurrent or refractory tumors

✍ Rüdiger Wessalowski; Heidi Kruck; Hildegard Pape; Thomas Kahn; Reinhart Willers; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 3 views

waves in combination with platinum-based chemotherapy in ten children and 4 Institute of Statistics, Heinrich-Heine Univeradolescents with recurrent or refractory GCTs. sity, Du ¨sseldorf, Germany. ## RESULTS. Seven of ten patients with recurrent or refractory GCTs had objective responses. Of the

Docetaxel plus epidoxorubicin as neoadju

Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast : A single-center, Phase II study

✍ Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##